Patent: 5,132,287
✉ Email this page to a colleague
Summary for Patent: 5,132,287
| Title: | Methods of treating disorders which cause conglutinin deficiency |
| Abstract: | Human conglutinin, polyclonal, and monoclonal antibodies raised against human conglutinin, and their uses in therapy and diagnosis are described. Human conglutinin was obtained from human plasma by affinity chromatography with anti-bovine conglutinin antibody, has a relative molecular weight of 330 and 40 K unreduced and 66 K reduced as measured by SDS-PAGE, shows calcium-dependent and sugar inhibitable binding to complement-reacted immune complexes and zymosan, and immunological cross-reaction with anti-bovine conglutinin antibody. |
| Inventor(s): | Jensenius; Jens C. (Odense M, DK) |
| Assignee: | Novo Industri A/S (DK) |
| Application Number: | 07/441,792 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,132,287
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2009-07-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
